[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356862-105":59,"doc-detail-356862-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","proteasome-targeting-with-carfilzomib-induces-reactive-oxygen-species-mediated-apoptosis-in-hepatoblastoma","Proteasome Targeting with Carfilzomib Induces Reactive Oxygen Species-Mediated Apoptosis in Hepatoblastoma","","Hepatoblastoma is the most common malignant pediatric liver tumor, yet treatment largely relies on conventional chemotherapy. To discover actionable targets, gene set enrichment across three public HB datasets revealed consistent activation of the proteasome pathway and strong overexpression of the β5 subunit PSMB5. In HB patient-derived xenograft models, carfilzomib reduced viability, proliferation, and clonogenic growth and induced apoptosis, including in three-dimensional cultures. Bioinformatics and experiments showed ROS signaling driving drug sensitivity; scavenging ROS abolished cytotoxicity, supporting proteasome inhibition as precision therapy for HB.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/proteasome-targeting-with-carfilzomib-induces-reactive-oxygen-species-mediated-apoptosis-in-hepatoblastoma/356862/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/proteasome-targeting-with-carfilzomib-induces-reactive-oxygen-species-mediated-apoptosis-in-hepatoblastoma/356862.png","ImageObject",300,407,{"name":92,"@type":93},"Pentious","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What dataset-driven finding links hepatoblastoma to the proteasome pathway?","Question",{"text":112,"@type":113},"Gene set enrichment analysis of three publicly available hepatoblastoma datasets showed consistent proteasome pathway activation, with marked overexpression of the β5 proteolytic subunit encoded by PSMB5.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does carfilzomib affect hepatoblastoma models in the study?",{"text":117,"@type":113},"Carfilzomib targeting β5 reduced cell viability, proliferation, and clonogenic growth in dose-dependent fashion and induced apoptosis in HB patient-derived xenograft models, including three-dimensional cultures.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is reactive oxygen species (ROS) considered a key mediator of response?",{"text":121,"@type":113},"Carfilzomib activated apoptosis and ROS signaling; experiments showed increased ROS levels that correlated with drug sensitivity. Pharmacological scavenging of ROS completely abrogated carfilzomib-induced cytotoxicity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356862,1790459293,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Article  \nProteasome Targeting with Carfilzomib Induces Reactive Oxygen Species-Mediated Apoptosis in Hepatoblastoma  \nElena Johanna Weigl 1, Salih Demir 1, Alina Hotes 1, Emilie Indersie 2, Sophie Branchereau 3, Stefano Cairo 4 and Roland Kappler 1, *  \n1 Department of Pediatric Surgery, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, Lindwurmstreet 2a, 80337 Munich, Germany  \n2 XenTech, 91000 Evry, France  \n3 Bicêtre Hospital, AP-HP Paris Saclay University, 94270 Le Kremlin-Bicêtre, France  \n4 Champions Oncology, Rockville, MD 20850, USA  \n* Correspondence: roland.kappler@med.uni-muenchen.de  \nAcademic Editor: Edward  \nV. Prochownik  \nReceived: 25 March 2026  \nRevised: 27 April 2026  \nAccepted: 7 May 2026  \nPublished: 9 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nHighlights  \nWhat are the main findings?  \n• The proteasome β5 subunit (PSMB5) is overexpressed in hepatoblastoma.  \n• Proteasome inhibition induces reactive oxygen species signaling and apoptosis in hepatoblastoma models.  \nWhat are the implications of the main findings?  \n• PSMB5 may predict response to proteasome inhibition.  \n• The proteasome inhibitor carfilzomib shows promise as a targeted therapy for hepatoblastoma.  \nAbstract  \nHepatoblastoma (HB) is the most common malignant liver tumor in children, yet therapeutic options remain largely confined to conventional chemotherapy. To identify novel therapeutic targets, we performed gene set enrichment analysis on three publicly available HB datasets and found consistent activation of the proteasome pathway, with marked overexpression of the β5 proteolytic subunit encoded by PSMB5 . High PSMB5 expression was associated with poor survival in adult hepatocellular carcinoma, highlighting the proteasome as a candidate for therapeutic vulnerability. Targeting the β5 proteolytic subunit with its selective inhibitor carfilzomib in HB patient-derived xenograft (PDX) models resulted in dose-dependent reductions in cell viability, proliferation, and clonogenic growth, accompanied by induction of apoptosis. Importantly, carfilzomib retained efficacy in threedimensional PDX cultures, underscoring its activity in physiologically relevant tumor models. Bioinformatic analyses revealed that carfilzomib activates apoptosis and reactive oxygen species (ROS) signaling. Validation experiments in HB cells demonstrated increased ROS levels, with ROS induction correlating with drug sensitivity. Notably, pharmacological scavenging of ROS completely abrogated carfilzomib-induced cytotoxicity, establishing oxidative stress as a key mediator of therapeutic response. Together, these findings identify PSMB5 as a therapeutically actionable target in HB and support proteasome inhibition as a promising precision medicine strategy in HB.  \nKeywords: hepatoblastoma; proteasome inhibition; carfilzomib; reactive-oxygen-species pathway  \n1. Introduction  \nHepatoblastoma (HB) is the most frequent malignant liver tumor in children [1,2] . Hepatoblastoma is rare in absolute numbers, with a worldwide incidence of 1–2 cases per million children [3] . While many other tumor entities are now treated using tailored approaches and targeted therapies, HB treatment is still based on conventional chemotherapeutic agents, primarily cisplatin and doxorubicin [4,5] . Overall survival rates are favorable, reaching up to 95% at three years following standard-of-care neo-adjuvant chemotherapy and surgical resection of the tumor [5] . Nevertheless, despite the continuous effort to improve therapy options and treatment protocols, patients with advanced-stage and relapsed HB continue to experience significantly poorer outcomes [4,5] .  \nTargeted therapies are most effective when they focus on a specific molecular alteration [6] . The development of a tailored therapy for HB is ha","cbCaitjuL31RdyTE","https://ap.wps.com/l/cbCaitjuL31RdyTE","pdf",4620101,16,"English","# Highlights\n# Abstract\n# Keywords\n# 1. Introduction\n## Clinical context and outcomes in hepatoblastoma\n## Molecular rationale for targeted therapy\n## Proteasome biology and therapeutic vulnerability","[{\"question\":\"What dataset-driven finding links hepatoblastoma to the proteasome pathway?\",\"answer\":\"Gene set enrichment analysis of three publicly available hepatoblastoma datasets showed consistent proteasome pathway activation, with marked overexpression of the β5 proteolytic subunit encoded by PSMB5.\"},{\"question\":\"How does carfilzomib affect hepatoblastoma models in the study?\",\"answer\":\"Carfilzomib targeting β5 reduced cell viability, proliferation, and clonogenic growth in dose-dependent fashion and induced apoptosis in HB patient-derived xenograft models, including three-dimensional cultures.\"},{\"question\":\"Why is reactive oxygen species (ROS) considered a key mediator of response?\",\"answer\":\"Carfilzomib activated apoptosis and ROS signaling; experiments showed increased ROS levels that correlated with drug sensitivity. Pharmacological scavenging of ROS completely abrogated carfilzomib-induced cytotoxicity.\"}]","Proteasome Targeting with Carfilzomib Induces Reactive Oxygen Species-Mediated Apoptosis in Hepatoblastoma | PDF",1790127785,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31fdce805fe0a5bf39c32f0cf09c24b4.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96d2e2e8cc97bdadf444192298af5408.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67867775f879b9b35d6d84d89f2d9519.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35ad300ae1d118f3b4f1277ff8999b54.webp",980,1385]